These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 29239044)
1. Pathology and genetics of phaeochromocytoma and paraganglioma. Turchini J; Cheung VKY; Tischler AS; De Krijger RR; Gill AJ Histopathology; 2018 Jan; 72(1):97-105. PubMed ID: 29239044 [TBL] [Abstract][Full Text] [Related]
2. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318 [TBL] [Abstract][Full Text] [Related]
3. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea. Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185 [TBL] [Abstract][Full Text] [Related]
4. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma. Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434 [TBL] [Abstract][Full Text] [Related]
5. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324 [TBL] [Abstract][Full Text] [Related]
6. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome. Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314 [TBL] [Abstract][Full Text] [Related]
7. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients. Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in Western Sweden. Muth A; Abel F; Jansson S; Nilsson O; Ahlman H; Wängberg B World J Surg; 2012 Jun; 36(6):1389-94. PubMed ID: 22270996 [TBL] [Abstract][Full Text] [Related]
11. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations. Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168 [TBL] [Abstract][Full Text] [Related]
13. The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study. Schovanek J; Martucci V; Wesley R; Fojo T; Del Rivero J; Huynh T; Adams K; Kebebew E; Frysak Z; Stratakis CA; Pacak K BMC Cancer; 2014 Jul; 14():523. PubMed ID: 25048685 [TBL] [Abstract][Full Text] [Related]
14. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes. Benn DE; Richardson AL; Marsh DJ; Robinson BG Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077 [TBL] [Abstract][Full Text] [Related]
15. Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort. Dénes J; Swords F; Rattenberry E; Stals K; Owens M; Cranston T; Xekouki P; Moran L; Kumar A; Wassif C; Fersht N; Baldeweg SE; Morris D; Lightman S; Agha A; Rees A; Grieve J; Powell M; Boguszewski CL; Dutta P; Thakker RV; Srirangalingam U; Thompson CJ; Druce M; Higham C; Davis J; Eeles R; Stevenson M; O'Sullivan B; Taniere P; Skordilis K; Gabrovska P; Barlier A; Webb SM; Aulinas A; Drake WM; Bevan JS; Preda C; Dalantaeva N; Ribeiro-Oliveira A; Garcia IT; Yordanova G; Iotova V; Evanson J; Grossman AB; Trouillas J; Ellard S; Stratakis CA; Maher ER; Roncaroli F; Korbonits M J Clin Endocrinol Metab; 2015 Mar; 100(3):E531-41. PubMed ID: 25494863 [TBL] [Abstract][Full Text] [Related]
16. Tumour microenvironment in pheochromocytoma and paraganglioma. Martinelli S; Amore F; Canu L; Maggi M; Rapizzi E Front Endocrinol (Lausanne); 2023; 14():1137456. PubMed ID: 37033265 [TBL] [Abstract][Full Text] [Related]
17. Risk of metastatic pheochromocytoma and paraganglioma in Lee H; Jeong S; Yu Y; Kang J; Sun H; Rhee JK; Kim YH J Med Genet; 2020 Apr; 57(4):217-225. PubMed ID: 31649053 [TBL] [Abstract][Full Text] [Related]
18. [Pediatric pheochromocytoma and paraganglioma: an update]. Garnier S; Réguerre Y; Orbach D; Brugières L; Kalfa N Bull Cancer; 2014 Oct; 101(10):966-75. PubMed ID: 25373696 [TBL] [Abstract][Full Text] [Related]
19. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase. Gupta S; Zhang J; Erickson LA Endocr Pathol; 2017 Sep; 28(3):269-275. PubMed ID: 28752484 [TBL] [Abstract][Full Text] [Related]
20. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. Pasini B; Stratakis CA J Intern Med; 2009 Jul; 266(1):19-42. PubMed ID: 19522823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]